ȸ»ç¼Ò°³

¾¾¾ÆÀ̹ÙÀÌ¿À´Â ¹ÏÀ½°ú ½Å·Ú¸¦ ¹ÙÅÁÀ¸·Î
±Í»çÀÇ ±¹³», ÇØ¿ÜÁøÃâÀÇ ÆÄÆ®³Ê°¡ µÇ°Ú½À´Ï´Ù.

  • Ȩ
  • ȸ»ç¼Ò°³
  • Àλ縻(±¹¹®)

Àλ縻(±¹¹®)

¾¾¾ÆÀ̹ÙÀÌ¿À ȨÆäÀÌÁö ¹æ¹®À» ȯ¿µÇÕ´Ï´Ù.

biopharmaceutical, genericµîÀÇ Àü¹Ý¿¡¼­ Regulatory Affair, control, Manufacturing, clinical trials, Licensing In/Out, Global partnering ¹×
registration ±îÁöÀÇ °úÁ¤À» ±¹³» ¹× ±¹Á¦ÀûÀÎ ±âÁØ¿¡ ¸ÂÃç ÀǾàÇ°»ê¾÷¿¡¼­ ´Ù¾çÇÑ ¼­ºñ½º¸¦ Á¦°øÇÏ°íÀÚ ³ë·ÂÇÏ°í ÀÖ½À´Ï´Ù.

ƯÁ¤ºÐ¾ß, ¿¹¸¦µé¾î °³·®½Å¾à, infectious disease, orphan drug, oncology, All major therapeutic indicationsµî ÀûÀýÇÑ ¼­ºñ½º¸¦ Á¦°øÇÏ¿©
±¹, ³»¿Ü ±Û·Î¹ú±â¾÷À¸·ÎÀÇ ¼ºÀåÀ» µ½±âÀ§ÇØ ³ë·ÂÇÏ°í ÀÖ½À´Ï´Ù